SCHEMBL8260282

SCHEMBL8260282

C=C1C(=O)C2=C(OC(C)C2(C)C)c2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 4/20 0.52
POR P16435 4/20 0.52
IDO1 P14902 10/20 0.41
ELANE P08246 1/20 0.36
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
TP53 P04637 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
MAPT P10636 2/20 0.33
THRB P10828 2/20 0.33
CYP2C9 P11712 2/20 0.33
ALOX15 P16050 2/20 0.33
CYP2C19 P33261 2/20 0.33
RECQL P46063 2/20 0.33
BLM P54132 2/20 0.33
KMT2A Q03164 2/20 0.33
TDP1 Q9NUW8 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(3R)-Dunnione SCHEMBL103115 0.86 NQO1 (0.63) NQO1PORIDO1ELANEKDM4E
(3R)-Dunnione SCHEMBL29468606 0.86 NQO1 (0.63) NQO1PORIDO1ELANEKDM4E
Alpha-Dunnione SCHEMBL940069 0.81 NQO1 (0.56) NQO1PORIDO1ELANEKDM4E
(3R)-Dunnione SCHEMBL6052903 0.79 NQO1 (0.56) NQO1PORIDO1ELANEKDM4E
SCHEMBL8182473 0.73 NQO1 (0.42) NQO1PORIDO1ELANEKDM4E
SCHEMBL6052838 0.72 NQO1 (0.57) NQO1PORIDO1ELANEKDM4E
(3R)-Dunnione SCHEMBL8535310 0.71 NQO1 (0.47) NQO1PORIDO1KDM4EMEN1
SCHEMBL6052899 0.71 NQO1 (0.67) NQO1PORIDO1ELANEKDM4E
SCHEMBL3329489 0.71 NQO1 (0.50) NQO1PORIDO1ELANEKDM4E
SCHEMBL3331249 0.71 NQO1 (0.50) NQO1PORIDO1ELANEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1848432-B1 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases MD BIOALPHA CO LTD (KR) 2013-07-17 EP disclosed
WO-2006088315-A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF DISEASES INVOLVING OBESITY, DIABETES, METABOLIC SYNDROME, NEURO-DEGENERATIVE DISEASES AND MITOCHONDRIA DYSFUNCTION DISEASES MD BIOALPHA CO., LTD. (KR) 2006-08-24 WO disclosed